Overview

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Phase Ib clinical study of Decitabine and Paclitaxel combination therapy
Phase:
Phase 1
Details
Lead Sponsor:
Dong Wha Pharmaceutical Co. Ltd.
Treatments:
Albumin-Bound Paclitaxel
Azacitidine
Decitabine
Paclitaxel